Integra Wound Matrix (Thin) has received 510(k) clearance from the United States Food and Drug Administration.
Integra Wound Matrix (Thin) is a collagen-glycosaminoglycan wound matrix that maintains and supports a healing environment for wound management. The company expects to begin a full-market release of the product in April.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
